000 01715 a2200469 4500
005 20250515053337.0
264 0 _c20071030
008 200710s 0 0 eng d
022 _a1439-099X
024 7 _a10.1007/s00066-007-1583-7
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRades, Dirk
245 0 0 _aRadio(chemo)therapy plus resection versus radio(chemo)therapy alone for the treatment of stage III esophageal cancer.
_h[electronic resource]
260 _bStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
_cJan 2007
300 _a10-6 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aCombined Modality Therapy
_xstatistics & numerical data
650 0 4 _aDisease-Free Survival
650 0 4 _aEsophageal Neoplasms
_xmortality
650 0 4 _aEsophagectomy
_xmortality
650 0 4 _aFemale
650 0 4 _aGermany
_xepidemiology
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Recurrence, Local
_xmortality
650 0 4 _aNeoplasm Staging
650 0 4 _aPrevalence
650 0 4 _aRadiotherapy, Conformal
_xmortality
650 0 4 _aRetrospective Studies
650 0 4 _aSurvival Analysis
650 0 4 _aSurvival Rate
650 0 4 _aTreatment Outcome
700 1 _aSchulte, Rainer
700 1 _aYekebas, Emre F
700 1 _aHomann, Nils
700 1 _aSchild, Steven E
700 1 _aDunst, Juergen
773 0 _tStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
_gvol. 183
_gno. 1
_gp. 10-6
856 4 0 _uhttps://doi.org/10.1007/s00066-007-1583-7
_zAvailable from publisher's website
999 _c16790562
_d16790562